Yeah, disappointing response from the market today. The goal of the trial was to get FDA approval in the US, and it was achieved, so it's a bit perplexing, despite the fact it didn't meet secondary endpoints.
- Forums
- ASX - By Stock
- Ann: Pharmaxis Announces Results of Pivotal CF Clinical Trial
Yeah, disappointing response from the market today. The goal of...
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.001(5.00%) |
Mkt cap ! $25.07M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 2.0¢ | $9.876K | 474.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 152915 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 668372 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 152915 | 0.020 |
11 | 2297210 | 0.019 |
8 | 1431714 | 0.018 |
5 | 1216465 | 0.017 |
6 | 784995 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 668372 | 1 |
0.022 | 1060259 | 4 |
0.023 | 281375 | 1 |
0.024 | 771883 | 5 |
0.025 | 1121967 | 6 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
2.1¢ |
  |
Change
0.001 ( 3.96 %) |
|||
Open | High | Low | Volume | ||
2.1¢ | 2.1¢ | 2.1¢ | 198471 | ||
Last updated 13.15pm 28/03/2024 ? |
Featured News
SNT (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online